For the first time, scientists are able to directly compare the different kinds of injury that mechanical ventilation causes to cells in the lungs.
Eli Lilly reveals two-year data for experimental eczema treatment after FDA roadblock
Eli Lilly is bolstering the case for its experimental eczema treatment lebrikizumab with a first look at how patients fared after two years of maintenance